Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Hormone stimulation for fertility preservation did not increase relapse rate in women with breast cancer

Women who received hormone stimulation for fertility preservation did not have a higher relapse rate in breast cancer compared with unexposed control women in a study from Karolinska Institutet in Sweden published in Breast Cancer Research and Treatment.

6 Nov 2017

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

Pre-menopausal women with the most common type of advanced breast cancer are usually excluded from medical research unnecessarily, according to an expert panel at the Advanced Breast Cancer Fourth International Consensus Conference.

6 Nov 2017

CMS report on radiation oncology alternative payment model provides viable path to better cancer care

The American Society for Radiation Oncology today called on the Centers for Medicare and Medicaid Services to move forward urgently with the development of a radiation oncology alternative payment model following a new report to Congress from the Center for Medicare and Medicaid Innovation.

3 Nov 2017

An alternative approach to augmenting the effect of antibiotics in chronic CF lung infections

There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.

From Neem Biotech 3 Nov 2017

Four main genes linked to survival of pancreatic cancer patients

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

3 Nov 2017

Gut bacteria can influence how cancer responds to immunotherapy

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

2 Nov 2017

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.

2 Nov 2017

Preclinical studies show effectiveness of targeted therapy for glioblastoma

The targeted therapy onalespib has shown effectiveness in preclinical studies of glioblastoma by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

2 Nov 2017

Discovery of genetic markers could guide individualized treatments for advanced prostate cancer

Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer.

2 Nov 2017

Philips launches proof-of-concept pilot for digital pathology services at ehi Live 2017

Royal Philips, a leader in health technology, today announced the launch of a proof-of-concept pilot for digital pathology services at a large, multi-region, scale. Announced at ehi Live, the pilot will last up to 12 months and is designed to establish ease-of-adoption for a fully integrated and digitised national pathology service, across Scottish NHS providers.

From Philips Healthcare 2 Nov 2017

Study: More than 10% of cancer patients continue to take opioids after surgery

More than two million people in the United States are dependent on prescription opioid pain relievers, a number that continues to grow as the rate of opioid prescriptions has skyrocketed in the last 25 years.

1 Nov 2017

Repositive introduces first Global PDX Directory at AACR conference

The first Global PDX Directory for proprietary and open source PDX models is being introduced by Cambridge (UK) based benefit corporation, Repositive, at the American Association for Cancer Research’sInternational Conference, on Molecular Targets and Cancer Therapeutics, hosted in conjunction with the European Organisation for Research and Treatment of Cancer and the National Cancer Institute, in Philadelphia, USA, 26-30 October 2017.

1 Nov 2017

FDA grants accelerated approval to new treatment for mantle cell lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.

1 Nov 2017

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.

31 Oct 2017

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.

31 Oct 2017

Surveillance rather than surgery can be safe option for women with FEA lesions

The detection of certain non-cancerous "high risk" breast lesions can lead to surgical treatment in women, but one of the largest studies of a specific type of high-risk lesion, flat epithelial atypia (FEA), calls for close observation, rather than surgical removal of these lesions in most cases, according to study results published on the web site of the Journal of the American College of Surgeons in advance of print.

31 Oct 2017

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced today four teams of top researchers who will carry out an attack on cancers of the lung and pancreas using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated.

31 Oct 2017

New discovery challenges basic assumptions about the brain's cellular makeup

A discovery made by Junhwan Kim, PhD, assistant professor at The Feinstein Institute for Medical Research, is challenging science's longstanding beliefs regarding the cellular makeup of the brain. This breakthrough was outlined in a study recently published in the journal Molecular and Cellular Biochemistry.

30 Oct 2017

NASA’s “Twins Study” explores the effects space travel has on the human body

Preliminary results from NASA’s Twins Study have revealed some of the bodily changes that occurred in an astronaught, who spent almost one year in space, compared with his twin brother, who remained on earth.

30 Oct 2017

Oncology News and Research

Further Reading

FDA approves new drug Zelboraf for Erdheim-Chester disease

Hormone stimulation for fertility preservation did not increase relapse rate in women with breast cancer

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

CMS report on radiation oncology alternative payment model provides viable path to better cancer care

An alternative approach to augmenting the effect of antibiotics in chronic CF lung infections

Four main genes linked to survival of pancreatic cancer patients

Gut bacteria can influence how cancer responds to immunotherapy

Researchers develop new, three-step system to eliminate colorectal cancer

Preclinical studies show effectiveness of targeted therapy for glioblastoma

Discovery of genetic markers could guide individualized treatments for advanced prostate cancer

Philips launches proof-of-concept pilot for digital pathology services at ehi Live 2017

Study: More than 10% of cancer patients continue to take opioids after surgery

Repositive introduces first Global PDX Directory at AACR conference

FDA grants accelerated approval to new treatment for mantle cell lymphoma

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

Surveillance rather than surgery can be safe option for women with FEA lesions

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

New discovery challenges basic assumptions about the brain's cellular makeup

NASA’s “Twins Study” explores the effects space travel has on the human body

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News